As of 2026-10-06, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -4.16 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 52.95 USD, the upside of Terns Pharmaceuticals Inc is -107.86%.
Based on its market price of 52.95 USD and our intrinsic valuation, Terns Pharmaceuticals Inc (TERN) is overvalued by 107.86%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.16 - -4.16 | -4.16 | -107.86% |
| P/E | (16.51) - (17.77) | (20.74) | -139.2% |
| DDM - Stable | (9.92) - (70.61) | (40.26) | -176.0% |
| DDM - Multi | (0.50) - (2.78) | (0.85) | -101.6% |
| Market Cap (mil) | 6,116.78 |
| Beta | -1.83 |
| Outstanding shares (mil) | 115.52 |
| Enterprise Value (mil) | 5,592.04 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.47% |
| Cost of Debt | 5.00% |
| WACC | 6.22% |